Vice President Marketing
Europe, India and APAC
Vice President Corporate Communications
Steven N. Barlow
Vice President Investor Relations
EXL Named as Aflac Outstanding Partner of the Year for 2019
NEW YORK, June 25, 2020 - EXL (NASDAQ: EXLS], a leading operations management and analytics company, today announced it had been named as Outstanding Partner of the Year for 2019. EXL won in the Service category for improving Aflac’s ability to provide quick resolution to its’ end customers.
The New Income Protection - Leveraging machine learning to detect and prevent fraud in retirement accounts - LifeHealth.com
Financial institutions must take action to better identify and investigate fraud, as well as thwart future attempts by combining artificial intelligence (AI), machine learning, and business judgment with a thorough forensic investigation of fraudster motives and methods
By Varun Sood
How Life Sciences Companies Can Make a Difference During the COVID-19 Pandemic - Managed Healthcare Executive
Life sciences companies can use geographic analysis as the basis of forming partnerships with providers to improve health outcomes in areas likely to be hard-hit by the COVID-19 pandemic.
By Susan Willman
Preventing the Aftershocks from COVID-19 - Healthcare Business Today
While there is little that can be done to stop the aftershocks of an actual earthquake, the same is not true for those generated by COVID-19. At the most basic level, one of the most important steps both health plans and providers can take is to use predictive analytics to monitor utilization of services for chronic conditions so they can uncover care gaps and remediate them before conditions become catastrophic.
By Dr. Victor Collymore
How Life Sciences Companies Can Promote Greater Medication Adherence During COVID19 - PharmaExec
As the global COVID-19 pandemic has continued to develop, it has become apparent that people at the highest risk for complications are those who were already experiencing chronic conditions such as diabetes, chronic obstructive pulmonary disease (COPD), asthma and heart disease.
By John Pagliuca & Prasad Dindigal